FFR-Guided PCI Using Contemporary Drug-Eluting

Fractional flow reserve (FFR)-guided drug-eluting stenting reduces death, myocardial infarction or urgent revascularisation, as compared to medical therapy in patients with stable coronary artery disease (CAD), according to the results of the FAME 2 trial presented at the European Society of Cardiology’s (ESC) Congress. Whilst percutaneous coronary intervention (PCI) has been performed for more than 30 years, its benefits in terms of 'hard endpoints'...

Read More